Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC? Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, et al. Breast Cancer Res Treat 2020 Oct 17. pii: 10.1007/s10549-020-05970.

Read + Share

Amedeo Smart

Independent Medical Education

Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, et al. Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC? Breast Cancer Res Treat 2020 Oct 17. pii: 10.1007/s10549-020-05970.
PMID: 33068198